Human MIA PaCa-2 is a human pancreatic cancer cell line, established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. The cells exhibit CK5.6, AE1/AE3, E-cadherin, vimentin, chromogranin A, synaptophysin, SSTR2, and NTR1, but not CD56. It is widely used in pancreatic cancer research and therapy development.
This RFP / human MIA PaCa-2 cell line expresses the codon-optimized monomer RFP fluorescent marker. RFP was expressed under the enhanced EF1a Promoter. Cell line carries the Puromycin resistance.
The following expression cassette was integrated into the cell line’s genome:
Each cell showed RFP fluorescent signal. see a sample image below:
Sold at: 1 vial x (2 x 106 cells)/vial, see details in Product Manual.